NCT01217788View on ClinicalTrials.gov

Intranasal PH94B for Management of the Symptoms of Generalized Social Phobia

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

February 28, 2011

Study Completion Date

March 31, 2011

Conditions
Social PhobiaSocial Anxiety Disorder
Interventions
DRUG

PH94B intranasal spray

Comparison of PH94B single dose intranasal spray and Placebo single dose intranasal spray

Trial Locations (1)

10024

Medical Research Network, New York

Sponsors
All Listed Sponsors
lead

Pherin Pharmaceuticals, Inc.

INDUSTRY